sub:assertion {
  d:DB01436 v:identifier "DB01436" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB01436" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB01436> ;
    dv:drugbank-id "DB01436" ;
    dv:x-ahfs <http://bio2rdf.org/ahfs:88:16.00> ;
    dv:x-atc <http://bio2rdf.org/atc:A11CC03> ;
    dv:x-cas <http://bio2rdf.org/cas:41294-56-8> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:4445376> ;
    dv:x-dpd <http://bio2rdf.org/dpd:474517> ;
    dv:x-kegg <http://bio2rdf.org/kegg:D01518> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA164746469> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:5282181> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46505115> ;
    dct:description "Alfacalcidol is an active metabolite of Vitamin D, which performs important functions in regulation of the calcium balance and the bone metabolism. Alfacalcidol is Vitamin D-hormone analog which is activated by the enzyme 25-hydroxylase in the liver for systemic and in osteoblasts for local D-hormone actions. It possesses a unique pattern of pleiotropic effects on, e.g. gut, bone, pararthyroids, muscle and brain. Alfacalcidol is superior to plain vitamin D (cholecalciferol) because the final kidney activation of the latter is regulated by a negative feedback mechanism. (PMID:17438884,17668216)"@en ;
    dct:identifier "drugbank:DB01436" ;
    dct:title "Alfacalcidol"@en ;
    a dv:Drug ;
    rdfs:label "Alfacalcidol [drugbank:DB01436]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB01436> .
}